June 4, 2025 Sweden
SwedenBio: Strategic business expansion: Growing your business in the US
SwedenBIO’s Working Group for Business Strategy, in collaboration with EY, hosted a seminar focused on how Swedish life science companies can successfully navigate entry into the U.S. market.
Ulf Hannelius, President and CEO of Diamyd Medical, contributed with perspectives on the company’s experience engaging with the FDA and navigating the regulatory landscape surrounding their application processes.
The seminar was recorded on Monday, June 2, 2025.
Read the article on the seminar
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.